Nääri
| Industry | Pharmaceuticals |
|---|---|
| Founded | December 17, 2007 |
| Headquarters | Oberwil, Switzerland |
|
Key people
|
Prithi S. Kochhar (CEO) Dr. Manfred A. May (Chairman) Prof. Michael Oettel (Director) |
| Website | http://www.naari.ch |
Naari AG is a Pharmaceutical company based in Oberwil, Switzerland. Naari was founded on December 17, 2007. The company’s core expertise lies in manufacturing Active pharmaceutical ingredients and Finished Formulations, focusing exclusively on the female health segment with a special emphasis on high active female hormones.
Naari is headquartered in Oberwil, Switzerland. The company’s infrastructure includes manufacturing infrastructure in Kashipur, India and a state-of-the-art Research and Development facility in Noida, India.
Naari develops and manufactures a large range of women health care products including Active pharmaceutical ingredients (APIs), Formulations, Diagnostics. The products of Naari include:
Active Pharmaceutical Ingredients (APIs)
• Allylestrenol
• Disulfiram
• Estradiol
• Estradiol Benzoate
• Estradiol Valerate
• Ethinylestradiol
• Estriol
• Levonorgestrel
• Lynestrenol
• Nandrolone Decanoate
• Nandrolone Phenylpropionate
• Norethisterone
• Norethisterone Acetate
• Norethisterone Enanthate
• Thiopental Sodium
• Tibolone
• Tolnaftate
Formulations
• Mifetril (Mifepristone 200 mg)
• Misopro (Misoprostol 200 mcg)
• Fasile (Levonorgestrel BP 0.75 mg)
• Fasile 1.5 (Levonorgestrel BP 1.5 mg)
• Phem 21 (Levonorgestrel 0.15 mg & Ethinylestradiol 0.03 mg Tablets BP)
• Phem 28 (Levonorgestrel 0.15 mg & Ethinylestradiol 0.03 mg Tablets BP with Ferrous Fumarate 60 mg Tablets BP)
• Anes (Thiopental Sodium for Injection 0.5 gm /1.0 gm)
• Vivant tablets (Allylestrenol 5 mg)
• Regelle tablets (Norethisterone BP 5 mg)
...
Wikipedia